financetom
Business
financetom
/
Business
/
Air-conditioner firm Carrier trims forecasts as residential demand wilts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Air-conditioner firm Carrier trims forecasts as residential demand wilts
Oct 28, 2025 8:40 AM

(Reuters) -Carrier Global ( CARR ) lowered its 2025 sales and profit forecasts on Tuesday, as it faces weak demand for heating, ventilation and air-conditioning products from residential markets.

It also announced a buyback of up to $5 billion, sending its shares up 2.6% in early morning trading.

Carrier's sales in the Americas from residential markets fell 30% in the third quarter, as distributors cleared out bloated inventory levels.

A slump in the North American housing market, largely due to stubbornly high mortgage rates and a surge in home prices, has hurt demand for heating and ventilation.

Despite a slight easing in mortgage rates after the Federal Reserve cut interest rates in September, an uncertain economic outlook and tepid hiring are keeping prospective homebuyers on the sidelines.

"We are of the view that demand will not recover in earnest until rates come down materially and a new housing market inflects up - including more sales of existing homes," said Scott Davis, analyst at Melius Research.

Slowing residential sales were partially offset by commercial customers such as data centers that use Carrier's products to cool down IT servers powering artificial intelligence technologies.

Carrier expects full-year net sales of about $22 billion, compared with its earlier forecast of about $23 billion. It forecast 2025 adjusted profit per share of roughly $2.65, compared with $3 to $3.10 estimated earlier.

The Florida-based company reported a third-quarter adjusted net income of 67 cents per share, compared with analysts' expectations of 57 cents, per data compiled by LSEG.

(Reporting by Anshuman Tripathy and Aishwarya Jain in Bengaluru; Editing by Mrigank Dhaniwala and Devika Syamnath)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
U.S. Bancorp vice chair's plane crashed on Saturday, bank says it believes he was on board
U.S. Bancorp vice chair's plane crashed on Saturday, bank says it believes he was on board
Mar 30, 2025
March 30 (Reuters) - A plane registered to U.S. Bancorp's ( USB ) Vice Chair Terry Dolan crashed in Brooklyn Park, Minnesota on Saturday, the bank said in a statement on Sunday. The Minnesota-based lender said the medical examiner's office has not been able to confirm whether Dolan was on board, but we believe he was. In addition to vice...
'Pissed off' at Putin, Trump threatens tariffs on Russian oil if Moscow blocks Ukraine deal
'Pissed off' at Putin, Trump threatens tariffs on Russian oil if Moscow blocks Ukraine deal
Mar 30, 2025
By Andrea Shalal WEST PALM BEACH (Reuters) -U.S. President Donald Trump said on Sunday he was pissed off at Russian President Vladimir Putin and will impose secondary tariffs of 25% to 50% on buyers of Russian oil if he feels Moscow is blocking his efforts to end the war in Ukraine. Trump told NBC News he was very angry after...
Hundreds of thousands of eastern Canadians face power outages due to ice storm
Hundreds of thousands of eastern Canadians face power outages due to ice storm
Mar 30, 2025
TORONTO, March 30 (Reuters) - Over 300,000 Canadians faced power outages in parts of Ontario on Sunday as an ice storm pummeled the region over the weekend, according to electricity provider Hydro One. Environment Canada issued winter storm warnings for freezing rain in Ottawa, parts of Quebec and Ontario, with the risk of snow mixed with or transitioning to ice...
Experimental Lilly drug cuts genetic heart disease risk factor by 94% in trial
Experimental Lilly drug cuts genetic heart disease risk factor by 94% in trial
Mar 30, 2025
CHICAGO, March 30 (Reuters) - The highest dose of an experimental drug developed by Eli Lilly ( LLY ) significantly reduced levels of a genetically inherited risk factor for heart disease in a midstage trial, according to data presented at a major medical meeting on Sunday. The drug, lepodisiran, reduced levels of lipoprotein(a), or Lp(a), by an average of 93.9%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved